UAE becomes second country globally to approve MIMRYLO (rusfertide) for adults with polycythemia vera, a chronic blood disorder characterised by the overproduction of red blood cells

https://www.ede.gov.ae/w/uae-becomes-second-country-globally-to-approve-mimrylo-rusfertide-for-adults-with-polycythemia-vera-a-chronic-blood-disorder-characterised-by-the-overproduction-of-red-blood-cells